Miransertib

Miransertib Uses, Dosage, Side Effects, Food Interaction and all others data.

Miransertib is under investigation in clinical trial NCT01473095 (Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma).

Trade Name Miransertib
Generic Miransertib
Miransertib Other Names Miransertib
Type
Formula C27H24N6
Weight Average: 432.531
Monoisotopic: 432.206244797
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Miransertib
Miransertib

Innovators Monograph

You find simplified version here Miransertib

*** Taking medicines without doctor's advice can cause long-term problems.
Share